After using CDKs inhibitors to pretreat breast cancer cells with a higher level of RNF126, we observed that the cell-killing effect of ATR inhibitors could be counteracted by the inhibitors, in conjunction with an alleviates replication stress. Here, ATR is linked to breast cancer.